Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05845671
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-04-25
Brief Title:
Amivantamab With Tyrosine Kinase Inhibitors TKI for Advanced NSCLC With ALK ROS1 or RET Alterations
Sponsor:
Organization:
University of Colorado Denver